摘要:
Organic esters and thioesters characterized by the presence of a cyclopropane moiety, synthesis thereof, and compositions thereof for the control of mites and ticks.
摘要:
Compounds of the formula AND DERIVATIVES THEREOF, INCLUDING ESTERS, THIOESTERS, AND AMMONIUM AND METAL SALTS THEREOF, WHEREIN R1 is aryl, unsubstituted 2-furyl or 2-furyl substituted at the 5-position by halogen or NO2; R2 and R3 are H or CH3 and X is Cl or Br, are selective defoliating herbicides useful to control weeds in agriculture and horticulture, e.g., cultivation of corn, rice and cotton.
摘要:
For combating and preventing infections caused by a variety of microbes such as bacteria and Trichomonas vaginalis, new compounds of the formula WHEREIN X is O, S or NH; Y is O; S; -CH2-O-; -S-CH2-; -CH2-S-; -O-CH2-; -SO-; -SO-CH2-; CH2-SO-; -CH2-SO2-; -SO2-CH2- or -CA2-, A being H, methyl, ethyl or phenyl; and R1, R2 and R3 each represents alkyl, hydroxy, hydroxyalkyl, alkoxy, alkoxyalkyl, alkoxyalkoxy, mono- or dialkylaminoalkyl, dialkylaminoalkoxy, amino, acylamino, mono- or dialkylamino, alkylsulfonylamino, acyloxy, alkylsulfonyloxy, benzyloxy groups wherein each alkyl, alkoxy or acyl residue is not more than five carbon atoms and acyl is derived from a carboxylic acid; halogen; or hydrogen with the provision that when Y represents -CH2-, at least one of R1, R2, and R3 is other than hydrogen.
摘要:
Embodiments herein provide compounds and methods of making and using such compounds for prevention and treatment of multidrug resistant bacteria. In particular, embodiments are directed to anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria.
摘要:
The invention relates to biphenylcarboxamides of the formula (I) in which A, R, Z, X, Y, m and n are each as defined in the disclosure, to a plurality of processes for preparing these substances, to their use for controlling undesirable microorganisms, and to novel intermediates and their preparation.
摘要:
An objective of the present invention is to provide compounds that can effectively suppress the concentration of phosphorus in serum to effectively prevent or treat diseases induced by an increase in concentration of phosphate in serum. The compounds according to the present invention are compounds represented by formula (I) and pharmaceutically acceptable salts and solvates thereof: wherein A represents an optionally substituted five- to nine-membered unsaturated carbocyclic moiety or a five- to nine-membered unsaturated heterocyclic moiety, and represents a single bond or a double bond, R5 represents optionally substituted aryl or the like, Z represents —N═CHR6R7 or the like, R6 and R7 represent H, optionally substituted alkyl, optionally substituted aryl or the like, R101 and R102 together form ═O, and R103 and R104 represent H, or R101 and R104 together from a bond, and R102 and R103 together form a bond.
摘要:
The invention is directed to compounds of Formula I: wherein A, X, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, colon cancer, stomach cancer, hairy cell leukemia and non-small lung carcinoma; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including arthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.
摘要:
Glutamate receptor function in a mammal may be potentiated using an effective amount of a compound of formula R1-L-NHSO2R2 I in which R1 represents an unsubstituted or substituted aromatic or heteroaromatic group; R2 represents (1-6C)alkyl, (3-6C)cycloalkyl, (1-6C)fluoroalkyl, (1-6C) chloroalkyl, (2-6C)alkenyl, (1-4C)alkoxy(1-4C)alkyl, phenyl which is unsubstituted or substituted by halogen, (1-4C)alkyl or (1-4C)alkoxy, or a group, of formula R3R4N in which R3 and R4 each independently represents (1-4C)alkyl or, together with the nitrogen atom to which they are attached form an azetidinyl, pyrrolidinyl, piperidinyl, morpholino, piperazinyl, hexahydroazepinyl or octahydroazocinyl group; and L represents a (2-4C)alkylene chain which is unsubstituted or substituted by one or two substituents selected independently from (1-6C)alkyl, aryl(1-6C)alkyl, (2-6C)alkenyl, aryl(2-6C)alkenyl and aryl, or by two substituents which, together with the carbon atom or carbon atoms to which they are attached form a (3-8C)carbocyclic ring; and pharmaceutically acceptable salts thereof. Also disclosed are novel compounds of formula I, processes for preparing them and pharmaceutical compositions containing them.